• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070350-48
Device Problems Stretched (1601); Device Damaged by Another Device (2915)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/19/2019
Event Type  malfunction  
Manufacturer Narrative
Exemption number e2019001.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely the implanted stent interacted with the balloon catheter during post dilation causing the reported stretched stent and device damaged by another.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the procedure was performed to treat a de novo lesion in the moderately tortuous, 90% stenosed mid left anterior descending coronary artery.A non-abbott atherectomy device was used along with a non-abbott 2.5x15mm balloon at 20 atmospheres (atms) and another non-abbott 3x10mm balloon at 20 atms for pre-dilatation.A 3.5x48mm xience xpedition stent was deployed at 10atms, and a non-abbott 3.5x15mm non-compliant balloon was used at 28 atms for post-dilatation.It was confirmed by intravascular ultrasound that the stent had elongated 2-3mm due to the post-dilatation.No treatment or intervention was performed to treat the elongated implanted stent.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
A cine was received and reviewed by an abbott vascular clinical specialist.The reviewer concluded the following: i am unable to determine visually, if there is actual elongation of the stent as this would only be possible to see using intra-vascular imaging, specifically oct while using a high resolution 54 mm pullback technique which would allow for appropriate resolution for stent rendering that is detailed and accurate enough to make a clear judgement on stent elongation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9575734
MDR Text Key177808146
Report Number2024168-2020-00547
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 02/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/23/2022
Device Catalogue Number1070350-48
Device Lot Number9061441
Was Device Available for Evaluation? No
Date Manufacturer Received02/07/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age69 YR
Patient Weight69
-
-